ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

IRD vs BNTC // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Opus Genetics Inc. (NASDAQ) VS. Benitec Biopharma Inc. (NASDAQ) • 15-METRIC TALLY: IRD 1 — BNTC 3
■ METRIC PARITY
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IRD VS. BNTC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC IRD BNTC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -11.61% -7.66% -3.95 BNTC /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 29.10% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 2/9 +3.00 IRD /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.7 42.6 -2.87 BNTC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $303.7M $308.1M -$4.4M BNTC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR IRD REV BNTC REV IRD GROSS % BNTC GROSS % IRD FCF BNTC FCF
FY 2025 $14.2M $0 — — -$35.3M -$23.6M
FY 2024 $11.0M $0 — — -$25.6M -$19.6M
FY 2023 $19.0M $0 — — -$1.1M -$18.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IRD // BETA —
BNTC // BETA —